We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Walker & Dunlop
WD
$1.47B
| $733K | ﹤0.01% |
6,451
+800
| +14% | +$83.7K |
|
1077
TriNet
TNET
$3.22B
| $731K | ﹤0.01% |
7,537
| – | – |
|
1078
Korn Ferry
KFY
$4.36B
| $730K | ﹤0.01% |
9,702
| – | – |
|
|
CCC
1079
CCC Intelligent Solutions
CCC
$4.19B
| $729K | ﹤0.01% |
66,000
| – | – |
|
|
DNB
1080
DELISTED
Dun & Bradstreet
DNB
| $729K | ﹤0.01% |
63,300
+11,900
| +23% | +$132K |
|
|
UCTT
1081
Ultra Clean Holdings
UCTT
$4.21B
| $727K | ﹤0.01% |
18,200
+2,900
| +19% | +$119K |
|
1082
Werner Enterprises
WERN
$2.31B
| $727K | ﹤0.01% |
18,830
+3,000
| +19% | +$111K |
|
1083
Global Net Lease
GNL
$1.9B
| $725K | ﹤0.01% |
86,146
+26,700
| +45% | +$224K |
|
1084
Madison Square Garden
MSGS
$9.94B
| $723K | ﹤0.01% |
3,472
+600
| +21% | +$121K |
|
1085
CONMED
CNMD
$1.49B
| $721K | ﹤0.01% |
10,023
| – | – |
|
1086
Newmark Group
NMRK
$2.77B
| $713K | ﹤0.01% |
45,917
+6,000
| +15% | +$77.9K |
|
1087
International Bancshares
IBOC
$4.57B
| $712K | ﹤0.01% |
11,902
| – | – |
|
1088
nCino
NCNO
$2.26B
| $711K | ﹤0.01% |
22,500
+10,800
| +92% | +$342K |
|
1089
Amkor Technology
AMKR
$14.3B
| $709K | ﹤0.01% |
23,176
| – | – |
|
1090
Reynolds Consumer Products
REYN
$5.55B
| $709K | ﹤0.01% |
22,800
+9,300
| +69% | +$275K |
|
1091
Terex
TEX
$7.57B
| $707K | ﹤0.01% |
13,353
| – | – |
|
1092
Iovance Biotherapeutics
IOVA
$2.95B
| $702K | ﹤0.01% |
74,800
+11,500
| +18% | +$109K |
|
1093
International Paper
IP
$21.8B
| $702K | ﹤0.01% |
14,369
-2,783
| -16% | -$130K |
|
1094
HUB Group
HUBG
$2.55B
| $699K | ﹤0.01% |
15,388
+2,100
| +16% | +$93K |
|
1095
Insperity
NSP
$2.05B
| $699K | ﹤0.01% |
7,944
+900
| +13% | +$83.4K |
|
1096
Beam Therapeutics
BEAM
$2.74B
| $698K | ﹤0.01% |
28,500
+10,900
| +62% | +$282K |
|
1097
Rocket Lab Corp
RKLB
$51.2B
| $698K | ﹤0.01% |
71,700
| – | – |
|
1098
Dyne Therapeutics
DYN
$4.85B
| $693K | ﹤0.01% |
19,300
+3,400
| +21% | +$135K |
|
1099
Arrowhead Research
ARWR
$12.1B
| $692K | ﹤0.01% |
35,700
+5,200
| +17% | +$127K |
|
1100
Resideo Technologies
REZI
$3.1B
| $689K | ﹤0.01% |
34,200
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.